| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 85,731 | 96,938 | 92,278 | 90,430 | | Cost of Revenue | 57,027 | 63,963 | 63,317 | 59,531 | | | Gross Profit | 28,704 | 32,975 | 28,961 | 30,899 | | | Operating Expenses | | Research Development | 5,274 | 4,309 | 4,412 | 3,793 | | Selling General and Administrative | 26,386 | 23,684 | 22,596 | 21,531 | | Non Recurring | (5,522) | 1,627 | 3,895 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,566 | 3,355 | (1,942) | 5,575 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (140) | 338 | (405) | (271) | | Earnings Before Interest And Taxes | 2,426 | 3,693 | (2,347) | 5,304 | | Interest Expense | 549 | 667 | 621 | 480 | | Income Before Tax | 1,877 | 3,026 | (2,968) | 4,824 | | Income Tax Expense | (4,112) | (160) |
-
| (1,999) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,989 | 3,186 | (2,968) | 6,823 | | | Non-recurring Events | | Discontinued Operations | (709) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,280 | 3,186 | (2,968) | 6,823 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,280 | $3,186 | ($2,968) | $6,823 |
|
0.02% Nasdaq 
0.14 (1.00%) 
Income Statement
